07.06.2017 • NewsElaine BurridgeShellalcohol

Shell Expands Alcohols at Geismar

(c) Shell
(c) Shell

Shell Chemical has made a final investment decision to expand mid-cut and low-cut fatty alcohol capacity at its plant in Geismar, Louisiana, USA, to meet growing demand for surfactant and plasticizer alcohols.

The company did not disclose the size of the expansion but said it plans to start commercial production of incremental alcohols at the same time as its fourth linear alpha olefins (LAO) unit, which is under construction and on track to start commercial operations by the end of 2018.

Increasing Geismar’s alcohol capacity helps Shell to adapt to changing market conditions by internally consuming both mid-cut linear alpha olefin and internal olefin feedstocks, the company stated.

The 425,000 t/y LAO plant is one of Shell’s largest investments in the US, noted Graham van’t Hoff, executive vice president for the group’s global chemicals business. Ethylene feedstock for the facility will be sourced from Shell’s Norco and Deer Park sites nearby. Once the expansion is completed, total capacity at Geismar will be 1.3 million t/y, making it the largest alpha olefins production site in the world.

Site preparations are also underway for Shell’s proposed petrochemicals complex in Pennsylvania, which will produce 1.6 million t/y of polyethylene using ethane produced from shale gas in the Marcellus and Utica basins. Main construction is scheduled to start in late 2017 with commercial production expected sometime after 2020.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read